CareFusion 303, Inc.

FDA inspection history across 2 sites, 2020 to 2024

2
Form 483s
1
Warning letter

Every document, by year

  • Warning letter
  • Form 483

2020: two Form 483s; 2024: one warning letter.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2020Two Form 483s, at San Diego, California.
  2. 2020The longest 483 on file: 8 observations over 13 pages.
  3. 2024One warning letter, at Franklin Lakes, New Jersey.

Cited most

Across all CareFusion 303 observations on file

The complete CareFusion 303 file.

All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$297

The price of the documents, added to your cart together

Sites

Also: one document not tied to a site.

Documents

3 on file, newest first
DateDocumentPrice
2024-11-22Warning letter Warning letter$99
2020-04-06483 Form 483$99
2020-03-02483 Form 483$99

Investigators on these documents

Janet Pulver (2)

FEI number 2016493 · most recent document Nov 22, 2024

About CareFusion 303, Inc.

How many FDA Form 483s has CareFusion 303, Inc. received?

FDA Intel has 2 Form 483s on file for CareFusion 303, Inc.; the most recent is dated Apr 6, 2020.

When was CareFusion 303, Inc. last inspected by FDA?

The most recent FDA inspection document on file for CareFusion 303, Inc. is a Form 483 dated Apr 6, 2020.

What did FDA cite at CareFusion 303, Inc.?

The regulations cited most in the observations on file for CareFusion 303, Inc. are 21 CFR 820.198 (Complaint files), 4 times; 21 CFR 820.30 (Design controls), 4 times; 21 CFR 803.17 (What are the requirements for developing, maintaining, and implementing written MDR procedures that apply to me?), 2 times.

Has CareFusion 303, Inc. received an FDA warning letter?

Yes. FDA Intel has 1 FDA warning letter on file for CareFusion 303, Inc.; the most recent is dated Nov 22, 2024.